drugset / Trial / NCT00884494

Ghrelin and Insulin Resistance

NCT00884494

Phase 1 Completed 20 enrolled Vanderbilt University Medical Center
RandomizedCrossoverSingle-blindBasic science

Summary

Ghrelin, a hormone produced in the stomach that stimulates hunger and food intake, declines immediately after weight loss surgery. Some studies suggest that ghrelin may worsen an individual's ability to respond to insulin. The purpose of this study is to determine if the decline in ghrelin levels after weight loss surgery contributes to the improvement of insulin sensitivity.

Timeline

Start
2011-08
Primary completion
2014-05
Completion
2014-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Ghrelin Peptide

Indications